Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 417-310-0 | CAS number: 72903-27-6
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Acute Toxicity: oral
Administrative data
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- From 29 Nov. 1994 to 21 Dec. 1994
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 995
- Report date:
- 1995
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 420 (Acute Oral Toxicity - Fixed Dose Method)
- Version / remarks:
- Adopted 17th July 1992
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.1 bis (Acute Oral Toxicity - Fixed Dose Procedure)
- Deviations:
- no
- Principles of method if other than guideline:
- not applicable
- GLP compliance:
- yes (incl. QA statement)
- Test type:
- fixed dose procedure
- Limit test:
- no
Test material
- Reference substance name:
- -
- EC Number:
- 417-310-0
- EC Name:
- -
- Cas Number:
- 72903-27-6
- Molecular formula:
- C12H20O4
- IUPAC Name:
- 1,4-diethyl cyclohexane-1,4-dicarboxylate
- Test material form:
- liquid
- Details on test material:
- Test material identification: ST 02 C 94
Description: colourless liquid
Date received; 25th November 1994
Constituent 1
- Specific details on test material used for the study:
- Storage conditions: refrigerator in the dark
Test animals
- Species:
- rat
- Strain:
- other: Crl: CD (SD) BR strain (VAF plus)
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River (UK)Limited, Margate, Kent- U.K.
- Age at study initiation: 4-6 weeks
- Weight at study initiation: See Tables of results
- Fasting period before study: yes overnight
- Housing: in groups ofup to 5, by sex, in grid-bottomed cages suspended over cardboard lined excreta trays. Cardboard tray liners were changed as often as necessary to maintain hygiene.
- Diet (e.g. ad libitum): ad libitum apart from an overnight fast before dosing (a pelleted diet (SQC Rat and Mouse Maintenance Diet No.1 Expanded, produced by Special Diets Services, Witham, Essex). Certificates of analysis for both diet and drinking water are held on file at Toxicol Laboratories.
- Water (e.g. ad libitum): ad libitum apart from an overnight fast before dosing
- Acclimation period: at least 5 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 21-24 °C
- Humidity (%): 40-66%
- Air changes (per hr): air conditionned room
- Photoperiod (hrs dark / hrs light): 12/12
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- CMC (carboxymethyl cellulose)
- Details on oral exposure:
- VEHICLE
- Concentration in vehicle: 25 & 100 mg/mL
- Amount of vehicle (if gavage): 20 mL/kg bw
MAXIMUM DOSE VOLUME APPLIED: 20 mL/kg bw
DOSAGE PREPARATION (if unusual): N.A. - Doses:
- Preliminary range finding study: 1 female with 500 mg/kg bw, then another female with 2000 mg/kg bw.
Main Study: 2000 mg/kg/bw (5 males + 5 females) - No. of animals per sex per dose:
- 5
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing: Observations: after 0.5, 1, 2, 4 hours and daily during 14 days. Weighing: Before dosing and weekly therafter (days 1, 8 and 15).
- Necropsy of survivors performed: yes
- Other examinations performed: clinical signs, body weight. - Statistics:
- Not applicable/relevant
Results and discussion
- Preliminary study:
- 1 female with 500 mg/kg bw: no clinical signs
1 female with 2000 mg/kg bw: no clinical signs
Effect levels
- Key result
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 2 000 mg/kg bw
- Based on:
- test mat.
- Mortality:
- none (see "Illustration" for detailed results)
- Clinical signs:
- other: none (see "Illustration" for detailed results)
- Gross pathology:
- no significant effects (see "Illustration" for detailed results)
- Other findings:
- None
Any other information on results incl. tables
none
Applicant's summary and conclusion
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- Oral LD50 combined > 2000 mg/kg bw
- Executive summary:
Introduction. The purpose of this study was to assess the acute oral toxicity of Fructalate, in the rat using the Fixed Dose Method. The study complies with the requirements of OECD Guideline for the Testing of Chemicals No 420, adopted 17th July 1992 and method B.1bis described in 0.J. L 383 A, an Annex to EEC Commission Directive 92/69/EEC of 31st July 1992.
These guidelines require that the main study be conducted at one (or more if necessary) of the following fixed dose levels: 5, 50, 500 or 2000 mg/kg bw.
Method. In a preliminary range finding study, the test article was administered orally at a dose level of 500 mg/kg bw to a single female rat. As this first animal was still alive 24 hours after dosing, a second female wasdosed with 2000 mg/kg bw test article. Both animals were examined frequently on the day of dosing and daily thereafter for a further 7 days. As neither animal exhibited clinical signs of toxicity and both were alive at the end of the observation period, no further range finding animals were dosed.
Since the results of the range finding study indicated that a test article dose of 2000 mg/kg bw produced no significant toxicity, in the main study, the test article was administered as a single oral dose of 2000mg/kg bw to a group of 5 male and 5 female rats which had been fasted overnight. The animals were examined frequently on the day of dosing and daily thereafter for a further 14 days at the end of which, they were killed and subjected to necropsy.
None of the animals died and all maintained a healthy appearance throughout the 15 days observation period.
There was no adverse effect on bodyweight gain in animals of either sex.
At necropsy, the submandibularlymph nodes were swollen in one male. No abnormalities were detected in the remaining animals.
Conclusions. Both the discriminating dose and the minimum lethal dose of the test material are estimated to be in excess of 2000 mg/kg bodyweight. According to the criteria in the guidelines quoted above, the test material is considered not to have significant acute toxicity under the conditions of this study.
The test material does not meet the criteria for classification according to the Regulation( EC) No. 1278/2008 (CLP)
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.